SS Innovations develops surgical robotics, led by its SSi Mantra system designed as a more cost-accessible alternative for multi-specialty procedures, including cardiac surgery. The platform is complemented by instruments, training tools and related robotic technologies aimed at hospitals seeking robotic capability without the highest-end price tiers. Founded by a robotic cardiac surgeon, the company positions itself around making advanced robotic surgery more widely available.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 5.1 | — | -5.7 | — |
| Q2 2025 | 10 | — | -0.3 | — |
| Q3 2025 | 12.8 | — | -3.7 | — |
| Q4 2025 | 14.5 | — | -2.5 | — |
| Q1 2026 | 11.1 | 116.8% | -3.6 | — |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Midland States Bancorp, Inc. (MSBI), Oculis Holding AG (OCS), Array Technologies, Inc. (ARRY), Stratasys Ltd. (SSYS), Verra Mobility Corporation (VRRM), Terrestrial Energy Inc. (IMSR)